TrialHuman vaccines & immunotherapeutics2013

Reactogenicity and safety of a liquid human rotavirus vaccine (RIX4414) in healthy adults, children and infants in China: randomized, double-blind, placebo-controlled Phase I studies.

Rong-Cheng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.